ENvue Medical (FEED) EBT Margin (2014 - 2026)
ENvue Medical's (FEED) quarterly EBT Margin came in at 2050.63% in Q2 2026, down 125933.0% year-over-year from N/an in Q2 2025, and down 253.41% quarter-over-quarter from 580.25% in Q1 2026.
Powered by 
Analysis
ENvue Medical (FEED) EBT Margin (2014 - 2026) Analysis & Trends
ENvue Medical (FEED) has reported EBT Margin for 13 consecutive years, with 2050.63% the latest figure, recorded in Q2 2026.
- On a quarterly basis, EBT Margin fell 125933.0% year-over-year to 2050.63% in Q2 2026; TTM through Jun 2026 was 819.78%, a 85082.0% increase from a year earlier, with the FY2025 full-year figure at 732.98%, up 58540.0% from the prior year.
- EBT Margin was 2050.63% for Q2 2026 at ENvue Medical, down from 580.25% in the prior quarter.
- Over five years, EBT Margin peaked at 7671.15% in Q4 2025 and troughed at 5451324.51% in Q4 2022.
- A 5-year average of 302674.63% and a median of 264.89% in 2022 frame the typical range for EBT Margin.
- Across the five-year window, EBT Margin plunged 545468632 bps in 2022 and surged 545189078 bps in 2023, its largest moves.
- Over 5 years, EBT Margin stood at 5451324.51% in 2022, then surged by 100 bps to 566.27% in 2023, then surged by 140 bps to 1359.23% in 2024, then surged by 464 bps to 7671.15% in 2025, then sank by 127 bps to 2050.63% in 2026.
- The last three EBT Margin figures came in at 2050.63% (Q2 2026), 580.25% (Q1 2026), and 7671.15% (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 12.10% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 36.46% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.13% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 23.74% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 19.48% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.86% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | -1.65% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.27% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 18.32% |
| 10 | ENvue Medical | 1.83 Mn | 685,650.21 | -266,000.00 | -2,050.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,050.63% |
| Mar 31, 2026 | -580.25% |
| Dec 31, 2025 | 7,671.15% |
| Sep 30, 2025 | 75.48% |
| Jun 30, 2025 | -791.30% |
| Mar 31, 2025 | -181.17% |
| Dec 31, 2024 | 1,359.23% |
| Sep 30, 2024 | -264.63% |
| Jun 30, 2024 | -83.72% |
| Mar 31, 2024 | -63.08% |
| Dec 31, 2023 | 566.27% |
| Sep 30, 2023 | -158.08% |
| Jun 30, 2023 | -360.88% |
| Mar 31, 2023 | -309.32% |
| Dec 31, 2022 | -5,451,324.51% |
| Sep 30, 2022 | -969.07% |
| Jun 30, 2022 | -265.15% |
| Mar 31, 2022 | -413.60% |
| Dec 31, 2021 | 3,361.81% |
| Sep 30, 2021 | -1,323.65% |